インサイダーの売却・購入履歴
| 自社株取引日 | 役員・従業員名 | 役員・従業員の役職 | 株式の種類 | 売却／購入 | 株数 | 株価 |
|---|---|---|---|---|---|---|
| 2024-02-12 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | 普通株式 | 購入 | 22,433 | $0.00 |
| 2024-02-12 | SWANSON, JAMES D. | EVP, CIO | 普通株式 | 売却 | 1,695 | $157.40 |
| 2024-02-12 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | 普通株式 | 売却 | 13,403 | $157.40 |
| 2024-02-12 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | 普通株式 | 売却 | 22,433 | $0.00 |
| 2024-02-12 | HAIT, WILLIAM | See Remarks | 普通株式 | 売却 | 7,647 | $0.00 |
| 2024-02-12 | FORMINARD, ELIZABETH | Executive VP, General Counsel | 普通株式 | 売却 | 1,034 | $157.40 |
| 2024-02-12 | WOLK, JOSEPH J | Exec VP, CFO | 普通株式 | 購入 | 22,119 | $0.00 |
| 2024-02-12 | WOLK, JOSEPH J | Exec VP, CFO | 普通株式 | 購入 | 3,716 | $0.00 |
| 2024-02-12 | WOLK, JOSEPH J | Exec VP, CFO | 普通株式 | 売却 | 10,816 | $157.40 |
| 2024-02-12 | WOLK, JOSEPH J | Exec VP, CFO | 普通株式 | 売却 | 22,119 | $0.00 |
| 2024-02-09 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 普通株式 | 売却 | 27,333 | $156.76 |
| 2024-02-09 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | 普通株式 | 購入 | 130,969 | $90.44 |
| 2024-02-09 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | ストックオプション | 売却 | 35,638 | $90.44 |
| 2024-02-09 | TAUBERT, JENNIFER L | EVP, WW Chair, Pharmaceuticals | ストックオプション | 売却 | 59,397 | $0.00 |
| 2024-02-09 | TAUBERT, JENNIFER L | EVP, WW Chair, Pharmaceuticals | 普通株式 | 売却 | 59,397 | $156.27 |
| 2024-02-09 | TAUBERT, JENNIFER L | EVP, WW Chair, Pharmaceuticals | 普通株式 | 購入 | 59,397 | $90.44 |
| 2024-02-09 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 普通株式 | 購入 | 35,638 | $90.44 |
| 2024-02-09 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | ストックオプション | 売却 | 130,969 | $90.44 |